HomeFileStructural heart disease

Structural heart disease

View Category

Other

TCT 2017 | PREVAIL: Final Outcomes of the Watchman Device

Courtesy of SBHCI. The final 5-year outcomes of the PROTECT AF and PREVAIL studies (which assessed the left...
solaci -
Learn More
SOLACI

TCT 2017 | The TRI-REPAIR and the FORMA Trials: New Devices for the “Forgotten Valve”

Courtesy of SBHCI. Two new transcatheter treatments for severe or massive functional tricuspid regurgitation have showed good results...
solaci -
Learn More
Mitral valve

TCT 2017 | INTREPID: Mitral Replacement with a Self-Expanding Device

Courtesy of the SBHCI. Intrepid is a 43-, 46-, and 50-mm nitinol self-expanding valve with bovine pericardial leaflets...
solaci -
Learn More
Mitral valve

TCT 2017 | MAVERIC: Results 6 Months After Transcatheter Mitral Valve Replacement

 Courtesy of the SBHCI. This seems to be the year for transcatheter mitral valve devices, and the ARTO...
solaci -
Learn More
Mitral valve

MitraClip Procedure Can Be Performed without General Anesthesia

Courtesy of Dr. Carlos Fava. Avoiding general anesthesia in intervention procedures has the benefits of faster recovery and...
solaci -
Learn More
Structural heart disease

The SOURCE 3 Confirms the Good Outcomes of the SAPIEN 3 at One Year Followup

Transcatheter aortic valve replacement (TAVR) was developed as a strategy to treat non-surgical aortic stenosis, and was later...
solaci -
Learn More
Structural heart disease

New Study Confirms TAVR Durability at 5 Years

The ADVANCE study was designed to evaluate the safety and effectiveness of transcatheter aortic valve replacement (TAVR)...
solaci -
Learn More
Coronary disease

Effects of Cerebral Radiation on Interventional Cardiologists

In recent years, there has been a growing concern about the occupational hazard for interventional cardiologists who...
solaci -
Learn More